Genicular Radiofrequency Ablation for Unilateral Knee Arthroplasty Pain Management
RFA
Comparison Between Cooled (C-RFA) and Standard (t-RFA) Radiofrequency Ablation, and Control for Pain Management Following Unilateral Knee Arthroplasty: A Double-Blinded, Parallel-Grouped, Placebo-Controlled Randomized Clinical Trial
1 other identifier
interventional
150
1 country
2
Brief Summary
Three primary reasons prolong hospital stays following unilateral knee arthroplasty. Pain is the primary reason followed by opioid drowsiness and nausea/vomiting side effects. Standard genicular radiofrequency ablation (t-RFA) has been effective pain management for non-operative knee pain associated with osteoarthritis. Additionally, cooled radiofrequency ablation (C-RFA), is now available for knee pain management. Both t-RFA and C-RFA offer minimally invasive, non-surgical, non-opioid pain relief options following surgery. The study will perform a double-blinded, parallel grouped, placebo-controlled randomized study to compare three pain management paradigms involving preoperative genicular C-RFA, t-RFA, and control placebo/sham. The aim of this study is to establish if C-RFA and t-RFA, offered preoperatively to patients undergoing unilateral knee arthroplasty, provide postoperative pain relief.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2017
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 3, 2016
CompletedFirst Posted
Study publicly available on registry
October 5, 2016
CompletedStudy Start
First participant enrolled
January 25, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 7, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 7, 2020
CompletedMay 24, 2019
May 1, 2019
3 years
October 3, 2016
May 22, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Postoperative analgesic consumption
Measure opioid consumption for the three study arms
0 - 3 weeks postoperatively
Hospital Length of Stay (LOS)
Measure hospital length of stay for the three study arms
0-5 days postoperatively
Secondary Outcomes (1)
Pain Score
before treatment arm procedures to 12 months after unilateral knee arthroplasty
Study Arms (3)
Standard Thermal radiofrequency ablation
EXPERIMENTALPatients randomized to t-RFA will receive standard genicular thermal radiofrequency ablation at least 3 weeks prior to unilateral knee arthroplasty for postoperative pain management.
Cooled radiofrequency ablation
EXPERIMENTALPatients randomized to C-RFA will receive cooled genicular thermal radiofrequency ablation at least 3 weeks prior to unilateral knee arthroplasty for postoperative pain management.
Control:Placebo Sham
SHAM COMPARATORPatients randomized to control will receive simulated genicular thermal radiofrequency ablation at least 3 weeks prior to unilateral knee arthroplasty and receive the industry standard of care for unilateral knee arthroplasty pain management.
Interventions
standard thermal genicular radiofrequency ablation
Cooled radiofrequency ablation
Simulated radiofrequency ablation for placebo controlled group
Eligibility Criteria
You may qualify if:
- Osteoarthritis of the knee where unilateral knee arthroplasty is indicated by radiograph, function decrease and/or pain indication and readiness to undergo t-RFA, C-RFA or sham treatment.
You may not qualify if:
- □ • NO DAILY OPIOID CONSUMPTION 5 WEEKS PRIOR TO ENROLLMENT
- NO DOCUMENTED NARCOTIC DEPENDENCY OR RECREATIONAL DRUG USE
- NO TOBACCO USAGE WITHIN 2 MONTHS PRIOR TO SURGERY
- NO CONFOUNDING INFLAMMATORY ARTHRITIS DISEASES ARE PRESENT
- NO NEUROPATHY OR NEURO IMPAIRMENT PRESENT
- NO SIGNIFICANT ACUTE ILLNESS OR INFECTION
- NO OTHER CONFOUNDING CHRONIC PAIN
- NO INVESTIGATIONAL AGENT WITHIN 3 MONTHS PRIOR TO ENROLLMENT
- NO DIAGNOSED THROMBOPHILIA
- NO SEVERE CARDIAC OR PULMONARY COMPROMISE
- NO BLEEDING DISORDER(S)
- NO ALLERGIC REACTION TO LOCAL ANESTHESIA, STEROIDS, OR IMPLANT MATERIALS
- NO BREASTFEEDING
- NO PREGNANCY
- NO CONFOUNDING PSYCHIATRIC ILLNESSES
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Lyman Medical Research Foundation, Inc.lead
- Halyard Healthcollaborator
Study Sites (2)
Orthopedic Specialty Institute
Coeur d'Alene, Idaho, 83814, United States
Orthopedic Specialty Institute
Spokane, Washington, 99202, United States
Related Publications (6)
Schiltenwolf M, Fischer C. Choi WJ et al. Radiofrequency treatment relieves chronic knee osteoarthritis pain: a double-blind randomized controlled trial. Pain 2011; 152: 481-7. Pain. 2011 Aug;152(8):1933-1934. doi: 10.1016/j.pain.2011.05.031. Epub 2011 Jun 22. No abstract available.
PMID: 21700390BACKGROUNDHusted H, Lunn TH, Troelsen A, Gaarn-Larsen L, Kristensen BB, Kehlet H. Why still in hospital after fast-track hip and knee arthroplasty? Acta Orthop. 2011 Dec;82(6):679-84. doi: 10.3109/17453674.2011.636682. Epub 2011 Nov 9.
PMID: 22066560BACKGROUNDKurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007 Apr;89(4):780-5. doi: 10.2106/JBJS.F.00222.
PMID: 17403800BACKGROUNDPatel A, Pavlou G, Mujica-Mota RE, Toms AD. The epidemiology of revision total knee and hip arthroplasty in England and Wales: a comparative analysis with projections for the United States. A study using the National Joint Registry dataset. Bone Joint J. 2015 Aug;97-B(8):1076-81. doi: 10.1302/0301-620X.97B8.35170.
PMID: 26224824BACKGROUNDStelzer W, Aiglesberger M, Stelzer D, Stelzer V. Use of cooled radiofrequency lateral branch neurotomy for the treatment of sacroiliac joint-mediated low back pain: a large case series. Pain Med. 2013 Jan;14(1):29-35. doi: 10.1111/pme.12014. Epub 2012 Dec 28.
PMID: 23279364BACKGROUNDLyman JR, Olscamp AJ, Lovell TP, Winegar CD, Wilson AN. Radiofrequency ablation prior to total knee arthroplasty does not improve post-surgical pain or recovery: a double-blinded, multi-center, randomized clinical trial. Ann Jt. 2023 Jan 15;8:5. doi: 10.21037/aoj-22-33. eCollection 2023.
PMID: 38529234DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jeffrey Lyman, MD
Orthopedic Specialty Institute
- PRINCIPAL INVESTIGATOR
Timothy Lovell, MD
Providence Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 3, 2016
First Posted
October 5, 2016
Study Start
January 25, 2017
Primary Completion
January 7, 2020
Study Completion
February 7, 2020
Last Updated
May 24, 2019
Record last verified: 2019-05